SteadyMed is positioned as a specialty pharmaceutical company, utilizing the unique PatchPump technology as the development platform. As a prefilled, large-volume system, PatchPump has the potential to fulfill needs both in the space beyond existing prefilled injector products, as well as in the chronic/continuous infusion space.
SteadyMed's development portfolio is founded on compounds that:
- Utilize the PatchPump technology platform to drive innovation in medical treatment paradigms
- Leverage existing internal technical/clinical/
regulatory/manufacturing expertise for risk-reduced development programs
- Maintain an agnostic view toward therapeutic area, yet allow for efficient commercial execution